(HealthDay)—The new coronavirus may be a respiratory bug, but it's becoming clear that some severely ill patients sustain heart damage. And it may substantially raise their risk of death, doctors in China are reporting.
Mar 26, 2020
0
0
James Diaz, MD, MHA, MPH & TM, Dr. PH, Professor and Head of Environmental Health Sciences at LSU Health New Orleans School of Public Health, has proposed a possible explanation for the severe lung complications being seen ...
Mar 23, 2020
2
9430
(HealthDay)—Most estimates show no differences in effectiveness between classes of antihypertensive agents, according to a systematic, multinational, large-scale analysis published online Oct. 24 in The Lancet.
Nov 1, 2019
0
1
Whether you need to take a drug at a specific time of day depends on the medication and the condition you are treating. For some medicines, it doesn't matter what time you take it. And for others, the pharmacist may recommend ...
Nov 1, 2019
0
2
(HealthDay)—A common type of blood pressure medication might be associated with an increased risk of suicide, a new study suggests.
Oct 17, 2019
0
395
Important medications for the treatment of heart failure are often prescribed in lower dosages than recommended by international guidelines. A study with the participation of the Medical University of Vienna shows overly ...
Oct 1, 2019
0
2
Dapagliflozin, a drug that is already used to successfully treat type 2 diabetes (T2D) and prevent development of heart failure, can also be used to treat pre-existing heart failure, even in patients without T2D.
Sep 19, 2019
0
5
Fibrosis, the damaging build-up of hardened or scarred tissue in the body, is a hallmark of various diseases and can lead to the dysfunction and failure of organs such as the heart and kidney. Fibrosis-related diseases in ...
Sep 12, 2019
0
11
A new meta-analysis published in The Lancet Diabetes and Endocrinology today has found that SGLT2 inhibitors can reduce the risk of dialysis, transplantation, or death due to kidney disease in people with type 2 diabetes.
Sep 5, 2019
0
118
A new meta-analysis published in Lancet Diabetes and Endocrinology today has found that SGLT2 inhibitors can reduce the risk of dialysis, transplantation, or death due to kidney disease in people with type 2 diabetes.
Sep 4, 2019
0
36
